18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
暂无分享,去创建一个
Thomas K Lewellen | Kristin Swanson | Mark Muzi | Satoshi Minoshima | David A Mankoff | Pam Pham | Alexander M Spence | Kenneth A Krohn | D. Mankoff | S. Minoshima | K. Swanson | T. Lewellen | M. Muzi | A. Spence | K. Krohn | J. Link | Jeanne M Link | Barbara Lewellen | Pam Pham | B. Lewellen | S. F. O’Sullivan | S Finbarr O'Sullivan
[1] H. Herzog,et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer , 1999, European Journal of Nuclear Medicine.
[2] Yoshiharu Yonekura,et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] C. Stearns,et al. Investigation of the count rate performance of the General Electric Advance positron emission tomograph , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.
[5] M. Graham,et al. High-speed automated discrete blood sampling for positron emission tomography. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Abass Alavi,et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[8] A. Blais,et al. 2-Deoxyglucose transport and metabolism in Caco-2 cells. , 1996, The American journal of physiology.
[9] V. Carey,et al. Mixed-Effects Models in S and S-Plus , 2001 .
[10] P. Marsden,et al. A PET study of 18FDG uptake in soft tissue masses , 1999, European Journal of Nuclear Medicine.
[11] E. Hoffman,et al. TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.
[12] T G Turkington,et al. Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Thomas K. Lewellen,et al. Investigation of the performance of the General Electric Advance positron emission tomograph in 3D mode , 1995 .
[14] Hiroshi Fukuda,et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection , 2001, European Journal of Nuclear Medicine.
[15] Finbarr O'Sullivan,et al. Reducing negativity artifacts in emission tomography: post-processing filtered backprojection solutions , 1993, IEEE Trans. Medical Imaging.
[16] A. Alavi,et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.
[17] I. Leav,et al. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models. , 1996, Nuclear medicine and biology.
[18] L M Hamberg,et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] T. Yen,et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Y Yonekura,et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] H. Sipilä,et al. Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[22] A. Alavi,et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[24] N. Alpert,et al. FDG-PET in oncology: there's more to it than looking at pictures. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] H. Sakahara,et al. Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas , 2000, Cancer.
[26] R. Maciunas,et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. , 1995, Radiology.
[27] S Minoshima,et al. An automated method for rotational correction and centering of three-dimensional functional brain images. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] F. O’Sullivan,et al. Metabolic images from dynamic positron emission tomography studies , 1994, Statistical methods in medical research.